U-CyTech Overview

  • Founded
  • 1999
  • Status
  • Private
  • Employees
  • 4
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 1

U-CyTech General Information


Developer of biomedical products designed to offer immunoassays for human, monkey and rodent use. The company's products include cytokine enzyme-linked immunosorbent assay, T and B cell assays and enzyme-linked Immuno spot systems which are designed for the ex vivo detection of individual protein secreting cells, enabling clients to prepare efficient medicines for their biological researches.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • Yalelaan 48
  • 3584 CM Utrecht
  • Netherlands
+31 085 000 0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

U-CyTech Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Early Stage VC 01-Jan-1999 Completed Startup
To view U-CyTech’s complete valuation and funding history, request access »

U-CyTech Executive Team (1)

Name Title Board Seat Contact Info
Peter Van der Meide Ph.D Founder, Owner & Chief Executive Officer
To view U-CyTech’s complete executive team members history, request access »

U-CyTech Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

U-CyTech Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Utrecht Holdings Venture Capital Minority 000 0000 000000 0
To view U-CyTech’s complete investors history, request access »